Morris Corporate Center III,
400 Interpace Parkway, NJ 07054
862-261-7000
Actavis plc (NYSE:ACT), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Actavis is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines, and biologic products for patients around the world.
Actavis markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women’s health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world’s third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Actavis is an industry leader in R&D, with one of the broadest development pipelines in the pharmaceutical industry.
With commercial operations in approximately 100 countries, Actavis is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
Actavis intends to adopt a new global name – Allergan – pending shareholder approval in 2015.
1 Cedar Brook Drive
Cranbury, NJ 08512
Phone: 609-662-2000
Fax: 609-662-2001
Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of therapies for rare and orphan diseases. The Company has a robust development pipeline of novel, first-in-class treatments for a broad range of human genetic diseases, with a focus on delivering new therapies to individuals with lysosomal storage disorders (LSDs).
Amicus is building a leading fully-integrated company in the area of rare diseases. The Company’s lead product candidate, migalastat, is a small molecule in development for Fabry disease, both as a monotherapy and in combination with enzyme replacement therapy (ERT). The Company is also leveraging its biologics and Chaperone-Advanced Replacement Therapy (CHART™) platform technologies to develop next-generation ERT products. Its lead biologics program is ATB200, a uniquely-engineered, next-generation Pompe ERT. Amicus is applying its CHART platform to combine ATB200 with a pharmacological chaperone to stabilize the administered enzyme in blood and potentially improve ERT tolerability and efficacy. Utilizing its biologics and CHART technologies, Amicus is also developing next-generation treatments for Fabry and MPS 1 with the potential to expand its pipeline into other LSDs.
2 Tower Center Boulevard, 20th Floor
East Brunswick, NJ 08816
Thomas Sullivan
732-509-8920
CBRE’s Life Sciences Group delivers a broad range of real estate services for the pharmaceutical, biotech and medical device industries. Our professionals have extensive knowledge of the unique challenges life science companies face for real estate and facility strategies and decisions. We are located in all major life science markets across the globe with experience that includes the full range from “Big Pharma” projects to early stage startups.
CBRE has the deepest platform in the industry and is the leading real estate firm for life sciences real estate. We are true experts in the NJ market.
CBRE’s Life Sciences Group (LSG) has the scope and experience to monitor and maintain current data and insights into the major and secondary pharmaceutical and biotech markets, leading to accurate valuations, realistic marketing plans and streamlined transaction execution.
This leads to specialized comparable data, industry experience and a global perspective on real estate planning, facility consolidation or expansion projects. Tom Sullivan is the recognized market expert for New Jersey.
For more information, please go to: www.cbre.com/lifesciences
210 Carnegie Center
Princeton, NJ 08540
Main Website:
www.covance.com
Careers Website:
www.careers.covance.com
Covance, the drug development business of LabCorp, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies. We have operations in over 60 countries around the globe.
Covance provides high-quality
nonclinical, clinical, and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development. We also offer laboratory testing services to the chemical, agrochemical and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services.
We’re moving science forward by leveraging the different perspectives and individual strengths of each and every Covance team member. Because here, we see diversity for exactly what it is — a driver of the business itself and the innovation that allows us to bring life-saving medicines to market sooner. And when you join us in this effort, you’ll enrich your life through exposure to new ways of thinking and the opportunity to learn with dynamic colleagues.
259 Prospect Plains Road
Bldg. K Suite 301, Cranbury, NJ 08512
Phone: 888-777-9733
Fax: 609-655-1708
Dynamic Strategies provides enterprise-level technology management and security designed specifically for smaller and mid-sized businesses.
As an IT Managed Services company specializing in data security, cloud services and infrastructure support for those with extremely sensitive intellectual property, Dynamic Strategies provides customized solutions to support your business needs featuring 24X7 monitoring of your key devices, applications and IT resources, remote and onsite maintenance, highest call priority and more.
Our proactive support model can remedy issues before they have a chance to impact your business. Benefits:
1 Normal Avenue
Montclair, NJ 07043
973-655-4000
Montclair State University’s College of Science and Mathematics advances the trans-disciplinary learning, innovative scholarship and leading-edge skills that develop tomorrow’s solutions – today.
A top-tier faculty delivers a challenging, comprehensive curriculum distinguished by discovery-based courses and research opportunities.
Rigorous degree programs include the state’s only PhD in Environmental Management, bachelor’s and master’s programs in Sustainability Science, a master’s in Pharmaceutical Biochemistry, a joint BS/PharmD with Rutgers University and Professional Science Masters (PSMs) in Sustainability Science and Information Technology. These and other programs cross disciplines to prepare graduates to respond to regional and global needs.
Scheduled to open in fall 2015, the new 107,000-square-foot Center for Environmental and Life Sciences will expand the University’s science research infrastructure by 50 percent.
Home to the Margaret and Herman Sokol Institute for Pharmaceutical Life Sciences, the PSEG Institute for Sustainability Studies, the Center for Quantitative Obesity Research and the Passaic River Institute, the College of Science and Mathematics fosters collaborative, interdisciplinary research and industry partnerships.
10 West Lafayette Street
Trenton, NJ 08608-2002
609-393-7707
The New Jersey Business & Industry Association (NJBIA) provides information, services and advocacy to its member companies in order to build a more prosperous New Jersey. The Association’s 20,000 member companies represent every industry in the state, including the life sciences. Widely regarded as the most well respected, credible and effective advocate for business in the state, NJBIA’s headquarters is strategically located near the State House, at 10 West Lafayette Street, Trenton.
NJBIA’s government affairs experts testify frequently before the Legislature and are vigilant in their efforts to protect the economic interests of our member companies. NJBIA is also working to advance the state’s higher education and business research collaboration so New Jersey companies have more resources to innovate and compete in the global marketplace. The Association also provides its members with important information to help them be successful on its website, www.njbia.org, through its monthly magazine New Jersey Business, and in its daily news service, New Jersey Business Today. In addition, NJBIA also offers a wide range of money-saving programs for its member companies. To learn more about the New Jersey Business & Industry Association, visit www.njbia.org.
1041 US Highway 202/206
Bridgewater, NJ 08807
Phone: 973-404-1543
Fax: 312-416-5497
Since acquiring the former Sanofi headquarters in Bridgewater, Advance Realty has made significant strides in repositioning the site into a premier R&D campus. An emerging regional hub for innovation, the New Jersey Center of Excellence boasts an in-place infrastructure that includes state-of-the-art lab facilities, redundant utilities and cutting-edge communications capabilities. These features enhance business continuity necessary for success in sectors such as bio-pharma, chemical and personal care.
There are several single- and multi-tenant spaces available for lease within the 800,000-square-foot campus. All spaces offer flexible configurations, with a minimum division of 2,700 square feet. In addition to the 500,000 square feet currently available, the campus offers 400,000 square feet of build-to-suit opportunities. Tenants will also benefit from the complex’s premium amenities package, which includes a full-service cafeteria, a fitness center, conference facilities, back-up generators and 24/7 security.
Perhaps most noteworthy is the campus’s proposed “town center.” The planned development of on-site hotel, retail, multi-family and restaurant components will result in a dynamic live-work-play environment for employees and will attract top-quality talent to this unique community.
NJIT 400 Fenster Hall
323 Dr Martin Luther King Jr. Blvd.
Newark, NJ 07102
973-596-5800
The New Jersey Innovation Institute (NJII) is an NJIT corporation focused on helping private enterprise discover what’s possible. Whether it’s working to solve the grand challenges shared across an entire sector or helping a single company find an innovative way to pursue a new product or market opportunity, NJII brings world-class intellectual and technological resources to bear. We are unique in our role as a not-for-profit corporation in pursuit of economic development and in our agility in transforming intellectual capital into commercial success. NJII has strategically organized Innovation Labs (iLabs) to follow industry-led agendas in healthcare, homeland defense, biotechnology and pharmaceutical production, civil infrastructure and financial services. NJII:
NJII is here to serve you. Bring us the challenges you face or the opportunities you want to pursue and we’ll match our innovation resources to your needs, to deliver a customized solution.
87 Prospect Avenue
Princeton, NJ 08544
Phone: 609-258-7256
Fax: 609-258-1584
Personalized attention, comprehensive services, innovative technologies: Welcome to Princeton University’s Office of Technology Licensing and Office of Corporate and Foundation Relations.
A life-saving cancer drug, a novel technology for energy-efficient lighting, chemicals for printed electronics that can revolutionize consumer packaging… These are some of the Princeton innovations that are making a difference in people’s lives and stimulating our economy.
Our offices connect industry partners, investors, and entrepreneurs with Princeton’s cutting-edge technologies and researchers to bring innovative solutions to real world problems.
The Office of Corporate and Foundation Relations facilitates sponsored research collaborations, and the Office of Technology Licensing facilitates company formation as well as licensing to startups and established corporations.
We welcome you to visit us at BIO 2015, booth #4217.
201 Mullica Hill Road
Glassboro NJ 08028
Phone: 856-256-5333
Fax: 856-256-4425
www.rowan.edu, www.sjtechpark.org
With a strong focus on STEM, Rowan University continues to grow its research presence two years after New Jersey designated it the second comprehensive public research institution in the state. Between 2011 and 2014, Rowan increased sponsored research from $11 million to $29 million, with funding from organizations such as the National Science Foundation and National Institutes of Health, and from corporations here and abroad. Rowan focuses on work that addresses real-world problems and provides real-world solutions. Teams conduct research related to health, energy, robotics and more, with the goal of developing intellectual property that will lead to the creation of companies that support the State’s economy. Rowan plans to increase research to $100 million by 2023.
Rowan offers bachelor’s through doctoral programs to close to 15,000 students in Glassboro, Camden and Stratford. In the past three years, Rowan created a School of Biomedical Sciences; opened Cooper Medical School of Rowan University; and incorporated the School of Osteopathic Medicine and the Graduate School of Biomedical Sciences, making Rowan only the second American university to grant both M.D. and D.O. degrees.
101 W. State St.
Trenton, N.J. 08608-1176
Phone: 888-442-8372
Fax: 609-984-8447
Whether you are advancing in your career or preparing for a new one, Thomas Edison State College has a program that fits your life and learning style. Offering opportunities for adult learners to leverage their college level knowledge is at the core of what we do, and we have been providing innovative degree programs since 1972 as a leader in the assessment of prior learning.
Through our Corporate Choice® Program, we partner with more than 25 companies to provide programs that fit their staff development, recruitment and retention needs.
The college has more than 21,000 students enrolled in programs encompassing more than 100 areas of study offered through our School of Applied Science and Technology, Heavin School of Arts and Sciences, School of Business and Management, W. Cary Edwards School of Nursing and John S. Watson School of Public Service and Continuing Studies.
Adults seeking to build their credentials in the fields of health sciences, healthcare administration, government affairs and health policy, clinical trials management, nursing, information technology or business are urged to visit us at www.tesc.edu.